摘要
细菌疗法和纳米技术都在各种疾病的诊断和治疗应用中表现出了非凡的潜力。在个人健康的不同方面,这些微纳米系统的个体影响也进行了研究;但是,一个集成系统细菌纳米粒子(NP)很少被探索。未被开发的细菌NP结合可能是一个新的诊断和治疗像疟疾,肺结核和癌症的传染性疾病的工具。,当哺乳动物细胞遇到外来因素,如细菌时,因为他们的防御机制会表现出细胞摄入。在这些哺乳动物细胞的吞噬作用中,细菌破裂,被溶菌酶溶解。一种携带药物标签NP的细菌会被以同样的方式被吞噬,最终到达靶细胞,在癌组织快速连续的细胞分裂,导致血管缺陷,细胞互连不完全,缺氧区和肿瘤细胞异质数量的发展。这些肿瘤细胞中散乱的和发育不良的血管再生使常规化疗药物选择性定位肿瘤很困难。目前情况下,在癌症/肿瘤细胞的诊断和治疗中,可以预料现有的先进的纳米细菌疗法是为了进一步治疗癌症靶向药物的方法。本文着重对细菌疗法在诊断和治疗癌症中的潜在应用。
关键词: 细菌疗法,纳米粒子,药物输送,癌症、缺氧、肿瘤治疗。
Current Medicinal Chemistry
Title:Prospects of Bacteriotherapy with Nanotechnology in Nanoparticledrug Conjugation Approach for Cancer Therapy
Volume: 23 Issue: 14
Author(s): Ritu Raj, Surajit Das
Affiliation:
关键词: 细菌疗法,纳米粒子,药物输送,癌症、缺氧、肿瘤治疗。
摘要: Bacteriotherapy and nanotechnology have shown remarkable potential in diagnostic and therapeutic applications for various diseases. Individual impacts of these micro-nano systems over different aspects of human health are well studied; however, an integrated system of bacteria-nanoparticle (NP) conjugation is less explored. The untamed potential of bacteria-NP conjugation could be a new tool for diagnosis and treatment of invasive diseases like malaria, tuberculosis and cancer. Mammalian cells exhibit cytosis as their defense mechanism when they encounter foreign elements such as bacteria. In these mammalian cells, during phagocytosis, bacteria are ruptured and lysed by lysozymes. A bacterium carrying the drug-tagged NP would be engulfed in the same manner and ultimately reaches the target cells. Rapid and continuous cell divisions in the cancer tissues lead to defective vessels, underdeveloped cellcell interconnects, development of hypoxic areas and heterogeneous population of tumor cells. This unorganized and poorly developed angiogenesis in tumor cells makes it difficult for conventional chemotherapeutic drugs to localize the tumors selectively. In the present scenario of diagnosis and treatment of cancer/tumor cells, it could be expected that the existing bacteriotherapy with the advanced nanotechnology would be a way further in the targeted drug delivery for cancer therapy. This review emphasizes the potential applications of bacteriotherapy with nanotechnology for the diagnosis and treatment of cancer.
Export Options
About this article
Cite this article as:
Ritu Raj, Surajit Das , Prospects of Bacteriotherapy with Nanotechnology in Nanoparticledrug Conjugation Approach for Cancer Therapy, Current Medicinal Chemistry 2016; 23 (14) . https://dx.doi.org/10.2174/0929867323666160406120923
DOI https://dx.doi.org/10.2174/0929867323666160406120923 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Simulating the Interactions of Toxins with K+ Channels
Current Pharmaceutical Design Enhanced Production of Cholesterol Oxidase from Bacillus sp. COX-T<sub>3</sub> in a Biphasic System
Current Biotechnology Revision and Implementation of “Clinical Guideline for Tuberculosis and HIV in Prisons”, Great Tehran Prison, Iran
Infectious Disorders - Drug Targets Potential Use of Protease Inhibitors as Vaginal and Colorectal Microbicides
Current HIV Research Editorial (Thematic Issue: Drug Delivery Australia)
Current Drug Delivery Synthesis of Novel Azetidinone Derivatives as Antitubercular Agents
Letters in Drug Design & Discovery Structural Analysis of Dihydrofolate Reductase and Thymidylate Synthase from Mammalian and Pathogenic Organisms
Current Enzyme Inhibition Adverse Drug Reactions to Anti-TB Drugs: Pharmacogenomics Perspective for Identification of Host Genetic Markers
Current Drug Metabolism The Immunocompromised Host: Immune Alterations in Splenectomized Patients and Clinical Implications
Current Pharmaceutical Design Targeting DNA Repair Systems in Antitubercular Drug Development
Current Medicinal Chemistry Microwave-Assisted Synthesis and Bioactivities of Novel Quinoline Lactones
Letters in Organic Chemistry Novel 2-hydrazino-pyrimidin-4(3H)-one Derivatives with Pseudofunctional- Similarity to Siderophores as Potential Antimycobacterial Agents
Medicinal Chemistry Structure-and-Mechanism-Based Design and Discovery of Type II Mycobacterium Tuberculosis Dehydroquinate Dehydratase Inhibitors
Current Topics in Medicinal Chemistry Recent Developments in Azole Compounds as Antitubercular Agent
Mini-Reviews in Organic Chemistry An Update on Autoinflammatory Diseases
Current Medicinal Chemistry Synthesis, Molecular Docking, and 2D-QSAR Modeling of Quinoxaline Derivatives as Potent Anticancer Agents against Triple-negative Breast Cancer
Current Topics in Medicinal Chemistry Pharmacogenomics – Implications in the Development of HIV-Associated Brain Disease
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Meet Our Executive Guest Editor
Current Topics in Medicinal Chemistry Benzothiazole: A Versatile and Multitargeted Pharmacophore in the Field of Medicinal Chemistry
Letters in Organic Chemistry Antibody - Fc Receptor Interactions in Antimicrobial Functions
Current Immunology Reviews (Discontinued)